Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Montalescot

Showing results (1-10 of 631) with videos related to

Pageof 64
Sort By:
Journal of the American College of Cardiology|April 25, 2015
Reply: Has Prasugrel Been Compared Correctly With Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome?Gilles Montalescot
Lancet (London, England)|August 19, 2008
Mechanical reperfusion: treat well, treat on time tooGilles Montalescot
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 23, 2010
Platelet biology and implications for antiplatelet therapy in atherothrombotic diseaseGilles Montalescot
European Heart Journal|September 8, 2004
Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?Gilles Montalescot
Journal of the American College of Cardiology|November 20, 2020
Non-ST-Segment Elevation Acute Coronary Syndrome: The Last Nail in the Coffin of Pre-TreatmentGilles Montalescot
Clinical Cardiology|November 14, 2002
Defining standards of care for facilitated and direct percutaneous coronary interventionGilles Montalescot
Nature Reviews. Cardiology|December 22, 2018
A farewell to aspirin in primary prevention?Gilles Montalescot
Circulation|November 8, 2006
Glycoprotein IIb/IIIa inhibitors in the elderly: fear of age or age of fear?Gilles Montalescot
Journal of the American College of Cardiology|February 20, 2016
Moving Toward Eradication of Stent ThrombosisOlivier Barthélémy, Gilles Montalescot
Journal of the American College of Cardiology|November 19, 2016
Reply: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?Farzin Beygui, Gilles Montalescot,
Pageof 64

Showing results (1-10 of 631) with videos related to

Sort By:
Pageof 64
Journal of the American College of Cardiology|April 25, 2015
Reply: Has Prasugrel Been Compared Correctly With Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome?Gilles Montalescot
Lancet (London, England)|August 19, 2008
Mechanical reperfusion: treat well, treat on time tooGilles Montalescot
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 23, 2010
Platelet biology and implications for antiplatelet therapy in atherothrombotic diseaseGilles Montalescot
European Heart Journal|September 8, 2004
Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?Gilles Montalescot
Journal of the American College of Cardiology|November 20, 2020
Non-ST-Segment Elevation Acute Coronary Syndrome: The Last Nail in the Coffin of Pre-TreatmentGilles Montalescot
Clinical Cardiology|November 14, 2002
Defining standards of care for facilitated and direct percutaneous coronary interventionGilles Montalescot
Nature Reviews. Cardiology|December 22, 2018
A farewell to aspirin in primary prevention?Gilles Montalescot
Circulation|November 8, 2006
Glycoprotein IIb/IIIa inhibitors in the elderly: fear of age or age of fear?Gilles Montalescot
Journal of the American College of Cardiology|February 20, 2016
Moving Toward Eradication of Stent ThrombosisOlivier Barthélémy, Gilles Montalescot
Journal of the American College of Cardiology|November 19, 2016
Reply: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?Farzin Beygui, Gilles Montalescot,
Pageof 64